Veradermics Inc (MANE) Stock Price, Quote & News

Company Profile

Veradermics, Incorporated, a clinical-stage biopharmaceutical company, focused on developing novel therapeutics for dermatologic and aesthetic conditions. The company develops treatments for Pattern Hair Loss affecting adults and children. The company's products include VDPHL01, an oral, non-hormonal treatment for men and women with PHL for chronic hair loss therapy. Additionally, it engages in the development of VDMN, a dissolvable microarray patch technology for immunotherapy of common warts;...

Industry: Biotechnology

Sector: Healthcare

Phone: (228) 372-3376

Website: www.veradermics.com

Address:

470 James Street, Suite 2, New Haven, United States

patternrank Jul. 31 at 1:02 PM

Today's 7-Day signals are out 🚀 Short-term setups ranked by confidence — no opinions, just models. Names showing up today: $SLN $CMPS $MANE (7D horizon · refreshed for 2026-07-31)

0 · Reply

MaverikIT Jul. 28 at 1:40 AM

@Jblack500 @No_Face_character @WAJeff @cynicaloptimist @BustaCapital @IsabellaDC Getting your $RYTM ? $MANE - not worrying about loosing your hair$ in this chitty market

1 · Reply

Alpha_Ascendant Jul. 27 at 11:01 AM

$MANE Veradermics is developing VDPHL01, a first-in-class non-hormonal oral minoxidil for pattern hair loss, with strong Phase 2/3 efficacy and safety data. I recommend a 'Hold' rating until late August due to its IPO lockup expiration next week (8/3): https://seekingalpha.com/article/4925764-veradermics-wait-for-the-post-lockup-buy-before-the-roll-up

0 · Reply

Colostrum Jul. 26 at 12:59 PM

$MANE is this a short

0 · Reply

MaverikIT Jul. 23 at 2:41 PM

@Jblack500 @BustaCapital @WAJeff @cynicaloptimist @IsabellaDC @No_Face_character $RVMD $MANE - not worry about loosing your hair$ in this market $AXSM - being awesome $CORT

1 · Reply

IN0V8 Jul. 16 at 3:14 PM

$MANE Buy Citigroup raises target price to $160 from $135

0 · Reply

flam70 Jul. 16 at 5:14 AM

$MANE does anyone think this stock is artificially high because people are locked up since the IPO and that once insiders etc can sell there will be pressure on the stock. It did go from 17 to 120

0 · Reply

Bullsarmy Jul. 15 at 11:20 PM

$MANE Nice gimme more.

0 · Reply

mikesterz7 Jul. 15 at 8:20 PM

$MANE In Veradermics’ Phase 2 trial for VDPHL01, female subjects showed an increase in hair count as early as the second month of treatment.

0 · Reply

topstockalerts Jul. 15 at 6:49 PM

$MANE there’s a certain stubbornness to this strength.

0 · Reply

Veradermics presents data from subgroup analysis of Phase 2/3 VDPHL01 study

Jul 17, 2026, 7:30 AM EDT - 14 days ago

Veradermics Announces Presentations of Data from a Subgroup Analysis of Phase 2/3 Study ‘302' in Males with Pattern Hair Loss at 2026 American Academy of Dermatology Innovation Academy

2026-07-16T10:45:34.000Z - 15 days ago

Veradermics price target raised to $160 from $135 at Citi

2026-07-15T17:33:42.000Z - 16 days ago

B. Riley Analyst Initiates Coverage of Veradermics Stock (MANE) With a Buy Rating

2026-07-15T14:05:24.000Z - 16 days ago

Veradermics rises 13.9%

Jul 15, 2026, 8:00 AM EDT - 16 days ago

Veradermics Transcript: Study result

Jul 15, 2026, 8:00 AM EDT - 16 days ago

Veradermics Press release: Study result

Jul 15, 2026, 8:00 AM EDT - 16 days ago

Veradermics Slides: Study result

2026-07-15T11:10:52.000Z - 16 days ago

Veradermics announces results from Phase 2 trial of VDPHL01

Jul 15, 2026, 7:00 AM EDT - 16 days ago

Veradermics' Oral VDPHL01 Delivers Positive Study ‘207' Phase 2 Clinical Trial Results in Female Pattern Hair Loss Ahead of Upcoming Phase 2/3 Study ‘306' Readout

2026-07-15T09:30:18.000Z - 16 days ago

Veradermics initiated with a Buy at B. Riley

Jul 14, 2026, 6:54 PM EDT - 17 days ago

Veradermics to Hold Conference Call to Discuss Study ‘207' Phase 2 Clinical Trial Results of VDPHL01 in Females with Mild-to-Moderate Pattern Hair Loss

2026-07-07T13:00:36.000Z - 24 days ago

Veradermics price target raised to $182 from $138 at Jefferies

Jun 25, 2026, 11:31 AM EDT - 5 weeks ago

Biotech ETF Index Surges 10% After Rebalance

ALKS APGE DFTX DYN KLRA KYMR MIRM

2026-06-16T11:24:24.000Z - 6 weeks ago

Veradermics initiated with an Outperform at LifeSci Capital

Jun 8, 2026, 2:00 PM EDT - 7 weeks ago

Veradermics Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 3, 2026, 3:10 PM EDT - 2 months ago

Veradermics Transcript: Jefferies Global Healthcare Conference 2026

2026-06-02T10:00:10.000Z - 2 months ago

Veradermics initiated with a Buy at Needham

May 28, 2026, 4:30 PM EDT - 2 months ago

Veradermics to Present at Upcoming June Investor Conferences

May 27, 2026, 7:30 AM EDT - 2 months ago

Veradermics Announces Poster Presentation on Topline Results from Phase 2/3 ‘302' Study of VDPHL01 at the 2026 World Congress for Hair Research

2026-05-18T11:25:16.000Z - 2 months ago

Veradermics price target raised to $135 from $120 at Citi

May 14, 2026, 7:30 AM EDT - 2 months ago

Veradermics Announces Two Poster Presentations on VDPHL01 at the 2026 Music City SCALE Symposium

May 12, 2026, 8:30 AM EDT - 2 months ago

Veradermics Earnings release: Q1 2026

May 12, 2026, 8:30 AM EDT - 2 months ago

Veradermics Quarterly report: Q1 2026

2026-05-12T11:57:22.000Z - 2 months ago

Veradermics reports Q1 net income ($27.2M) vs ($12.4M) last year

May 12, 2026, 7:30 AM EDT - 2 months ago

Veradermics Reports First Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress

2026-04-30T03:35:14.000Z - 3 months ago

Veradermics 3.84M share Secondary priced at $100.00

Apr 29, 2026, 10:32 PM EDT - 3 months ago

Veradermics Announces Pricing of Upsized Public Offering and Private Placement

2026-04-27T21:30:15.000Z - 3 months ago

Veradermics announces offering of 3.35M shares of common stock

Apr 27, 2026, 5:26 PM EDT - 3 months ago

Veradermics Announces Launch of Public Offering

2026-04-27T21:20:43.000Z - 3 months ago

Veradermics files to sell 3.35M shares of common stock

2026-04-27T18:46:21.000Z - 3 months ago

Veradermics price target raised to $120 from $85 at Citi

Apr 27, 2026, 8:00 AM EDT - 3 months ago

Veradermics Transcript: Study result

Apr 27, 2026, 8:00 AM EDT - 3 months ago

Veradermics Press release: Study result

Apr 27, 2026, 8:00 AM EDT - 3 months ago

Veradermics Slides: Study result

Apr 27, 2026, 8:00 AM EDT - 3 months ago

Veradermics Registration statement: Registration filing

2026-04-27T11:20:18.000Z - 3 months ago

Veradermics announces VDPHL01 met all primary, secondary endpoints

Apr 27, 2026, 7:00 AM EDT - 3 months ago

Veradermics' Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 2/3 ‘302' Clinical Trial in Male Pattern Hair Loss

Apr 26, 2026, 4:00 PM EDT - 3 months ago

Veradermics to Hold Conference Call to Discuss Topline Results from Phase 2/3 ‘302' Study of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss

Mar 30, 2026, 8:30 AM EDT - 4 months ago

Veradermics Annual report: Q4 2025

Mar 30, 2026, 8:30 AM EDT - 4 months ago

Veradermics Earnings release: Q4 2025

2026-03-30T11:36:51.000Z - 4 months ago

Veradermics reports Q4 net loss $21.8M vs $5.7M last year

Mar 30, 2026, 7:30 AM EDT - 4 months ago

Veradermics Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Corporate and Clinical Updates

Mar 18, 2026, 7:00 AM EDT - 4 months ago

Veradermics Announces Presentations on VDPHL01 and Patient Experiences With Pattern Hair Loss at 2026 American Academy of Dermatology Annual Meeting

Mar 10, 2026, 4:20 PM EDT - 5 months ago

Veradermics Transcript: Leerink Global Healthcare Conference 2026

Mar 3, 2026, 7:00 AM EST - 5 months ago

Veradermics to Participate in Upcoming March Investor Conferences

Feb 12, 2026, 8:55 AM EST - 6 months ago

NYSE Content Update: Forgent Power Solutions, Post IPO, to Ring Opening Bell

FPS

Feb 9, 2026, 7:30 AM EST - 6 months ago

Veradermics Completes Enrollment in Second Pivotal Phase 3 Clinical Trial of VDPHL01 for Male Pattern Hair Loss

Feb 5, 2026, 4:05 PM EST - 6 months ago

Veradermics Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering

Feb 3, 2026, 9:57 PM EST - 6 months ago

Veradermics Announces Pricing of Upsized Initial Public Offering

Feb 3, 2026, 7:00 AM EST - 6 months ago

Veradermics Slides: Corporate presentation

Jan 28, 2026, 7:00 AM EST - 6 months ago

Veradermics Registration statement: Registration Filing

Jan 9, 2026, 5:08 PM EST - 7 months ago

Veradermics, Dermatology Biopharma Focused on Hair Loss, Files for NYSE IPO

Jan 9, 2026, 5:04 PM EST - 7 months ago

Veradermics IPO Registration Document (S-1)

Jan 9, 2026, 3:13 PM EST - 7 months ago

Hair loss biotech Veradermics files for a $100 million IPO

patternrank Jul. 31 at 1:02 PM

Today's 7-Day signals are out 🚀 Short-term setups ranked by confidence — no opinions, just models. Names showing up today: $SLN $CMPS $MANE (7D horizon · refreshed for 2026-07-31)

0 · Reply

MaverikIT Jul. 28 at 1:40 AM

@Jblack500 @No_Face_character @WAJeff @cynicaloptimist @BustaCapital @IsabellaDC Getting your $RYTM ? $MANE - not worrying about loosing your hair$ in this chitty market

1 · Reply

Alpha_Ascendant Jul. 27 at 11:01 AM

0 · Reply

Colostrum Jul. 26 at 12:59 PM

$MANE is this a short

0 · Reply

MaverikIT Jul. 23 at 2:41 PM

@Jblack500 @BustaCapital @WAJeff @cynicaloptimist @IsabellaDC @No_Face_character $RVMD $MANE - not worry about loosing your hair$ in this market $AXSM - being awesome $CORT

1 · Reply

IN0V8 Jul. 16 at 3:14 PM

$MANE Buy Citigroup raises target price to $160 from $135

0 · Reply

flam70 Jul. 16 at 5:14 AM

$MANE does anyone think this stock is artificially high because people are locked up since the IPO and that once insiders etc can sell there will be pressure on the stock. It did go from 17 to 120

0 · Reply

Bullsarmy Jul. 15 at 11:20 PM

$MANE Nice gimme more.

0 · Reply

mikesterz7 Jul. 15 at 8:20 PM

$MANE In Veradermics’ Phase 2 trial for VDPHL01, female subjects showed an increase in hair count as early as the second month of treatment.

0 · Reply

topstockalerts Jul. 15 at 6:49 PM

$MANE there’s a certain stubbornness to this strength.

0 · Reply

StocktwitsNews Jul. 15 at 5:50 PM

Why Is MANE Stock Rising Today? $MANE https://stocktwits.com/news/equity/markets/why-is-mane-stock-rising-today-july-15-2026/cZZPaxfR7ra

0 · Reply

ETF_Trader1 Jul. 15 at 3:30 PM

$MANE is gaining attention after Veradermics reported positive Phase 2 results for VDPHL01 in female pattern hair loss. The oral treatment showed increases in non-vellus hair count after six months, with both once-daily and twice-daily dosing groups demonstrating consistent responses and generally favorable tolerability. Patient-reported outcomes also showed a high percentage of participants reporting improved hair coverage. The next major catalyst will be the upcoming Phase 2/3 Study 306 readout. While the results are encouraging, larger trials will be important to confirm durability, safety, and the potential commercial opportunity in the hair loss market.

0 · Reply

notreload_ai Jul. 15 at 2:03 PM

$MANE surges after B. Riley initiates coverage with a Buy rating and $170 PT. Positive Phase 2 data for VDPHL01 positions it as the first oral hair loss treatment for women. https://notreload.xyz/xy/veradermics-gets-buy-rating-strong-phase-2-hair-loss-data/

0 · Reply

BuyLongHoldStrong Jul. 15 at 1:50 PM

$MANE Glad to buy this as I know many who suffer from this condition. If this was available to Jada Pinkett, Will Smith wouldn’t have slapped Chris Rock.

0 · Reply

JFais Jul. 15 at 12:56 PM

$MANE - solid data in female hair loss as well. Trend of outperformance for recent IPOs continues $XBI

0 · Reply

OpenOutcrier Jul. 15 at 12:34 PM

$MANE (+8.0% pre) Veradermics reports positive Phase 2 results for oral hair loss drug https://ooc.bz/l/107842

0 · Reply

STACKD0E Jul. 15 at 11:13 AM

$PHIO $MANE $AXSM $GILT ✨️

0 · Reply

MaverikIT Jul. 9 at 3:07 PM

$MANE +6.75 - not worry about loosing your hair$

0 · Reply

prismmarketview Jul. 6 at 8:38 PM

$MANE has been a rocket: IPO at $17, late‑stage win in male pattern hair loss, and now up ~656%. With the obesity and aesthetics boom, this hair‑loss pill looks like a stealth GLP‑1 halo play. #MANE #biotech #hairloss #obesity #growthstocks https://prismmarketview.com/veradermics-rides-hair-loss-and-obesity-tailwinds-to-big-stock-gains/

0 · Reply

Exelariad Jul. 6 at 5:53 PM

$MANE it is a monster. The SP is performing amazingly. A Miracle!

0 · Reply

lozzamozza Jun. 29 at 4:16 PM

$MANE add

0 · Reply

MikeCaymanTrades Jun. 29 at 1:29 AM

$MANE Newer IPO classic broadening wedge long. 32.00 to 125.50

0 · Reply

Market Cap	N/A
Revenue (ttm)	0.00
Net Income (ttm)	0.00
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	N/A

Volume	934,600
Avg Vol	N/A
Day's Range	N/A - N/A
Shares Out	N/A
Stochastic %K	N/A
Beta	N/A
Analysts	Strong Buy
Price Target	N/A